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1200 utility weights associated with cardiovascular events and procedures. 
Stroke accounted for one-third of total identified cardiovascular utilities, 
followed by myocardial infarction (25%), heart failure (17%), and peripheral 
vascular disease (8%). Most (86%) of the utility estimates were derived from 
secondary references (e.g., published literature). Over one-third (36%) of utilities 
identified were elicited using EQ-5D and 14% were estimated with direct time 
trade-off questions. Among the utilities from published studies disclosing 
sample population information, nearly two-thirds (64%) were elicited from 
patients and 25 % from community members. Few studies (n=27 CUAs, 168 utility 
weights) reported utilities for asymptomatic or symptomatic states prior to the 
cardiovascular event or procedure. CONCLUSIONS: Heterogeneity exists in the 
reporting of cardiovascular utility weights. Analysts conducting CUAs using 
secondary references can improve study transparency by reporting relevant 
utility information, such as sample population, sample size, and assessment 
method. In order to better understand the cost-effectiveness of interventions for 
cardiovascular conditions, further research is needed to inform baseline utility 
measurement prior to cardiovascular events or procedures.  
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OBJECTIVES: Evaluate the psychometric properties of the revised version of the 
Medical Outcomes Study Cognitive Functioning Scale (MOS-Cog-R) using data 
from a representative sample of U.S. adults. METHODS: The 6-item MOS-Cog 
yields a single score representing impairment across a range of cognitive 
functions, including memory, reasoning, attention/concentration, and confusion, 
over the previous four weeks. The MOS-Cog-R introduced several changes: one 
response option was removed; a one-week recall period form was introduced; 
and 0-100 scoring was replaced by norm-based T-scores (mean=50, standard 
deviation=10), standardized using data from a 2009 U.S. internet-based general 
population normative survey to improve interpretability. The psychometric 
properties of both one-week (acute) and four-week (standard) recall forms of the 
MOS-Cog-R were examined within the development sample. Scale reliability was 
evaluated using inter-item correlations and Cronbach’s alpha. Construct validity 
was tested using correlations with relevant continuous criterion variables and 
analysis of covariance models comparing mean MOS-Cog-R scores across levels 
of categorical criterion variables. RESULTS: Acute and standard forms of the 
MOS-Cog-R were completed by 2012 and 2003 respondents, respectively. Both 
forms showed adequate internal consistency reliability (all inter-item 
correlations>0.40; both Cronbach's alphas≥0.89). MOS-Cog-R scores showed 
greater correspondence with mental domains of quality of life than physical 
domains (e.g., correlations for both forms with SF-12v2 mental and physical 
summary scores were ≥0.55 and ≤0.28, respectively). Direction and magnitude of 
correlations with criterion measures of psychological status (e.g., depression, 
anxiety) and health outcomes indicated good convergent validity for both forms. 
Differences in mean scores across respondents stratified by criterion outcomes 
supported adequate discriminant validity of each form. CONCLUSIONS: The 
MOS-Cog-R introduces a number of improvements, including simplified 
responses, the introduction of a one-week recall form, and norm-based scoring 
that enhances interpretability of scores. Both acute and standard recall-period 
forms of the MOS-Cog-R demonstrated good reliability and validity.  
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OBJECTIVES: To establish an EQ-5D-3L value set using time trade-off (TTO) 
values directly measured from the general Singaporean population. METHODS: 
The values of 80 EQ-5D-3L health states were directly elicited from a general 
Singaporean population sample using a TTO method modified from the MVH 
protocol. In face-to-face interviews, participants were asked to value a block of 
10 health states. Various linear regression models and model specifications were 
examined to assess their goodness of fit to the data, at both individual and 
aggregated levels, and ability to predict the values for measured and 
unmeasured EQ-5D-3L health states. Goodness of fit was assessed in terms of 
mean absolute error (MAE), numbers of prediction errors larger than 0.05 and 
0.10; while prediction ability was assessed in terms of logic consistency and bias. 
RESULTS: A total of 500 participants provided data for this study. The N3 model 
without a constant using the random-effects estimator exhibited the best fit of 
the data at individual level, predicted values with the least bias, and generated 
logically consistent values for all 243 EQ-5D-5L health states. The MAE was 
0.1227, and 41 out of 80 predicted values had errors less than 0.10 in absolute 
magnitude. Based on this model, the second highest utility value is 0.8867 for 
state 21,111and the lowest value is -0.7284 for state 33,333. CONCLUSIONS: This 
study established the value set of EQ-5D-3L health states for Singapore. The 
value set provides health services researchers in Singapore a useful tool for 
assessing the cost-effectiveness of health technologies and services.  
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OBJECTIVES: The Provider-Dependent Health Care Orientation (PDHCO; Kaplan 
1996) assesses an individual’s orientation towards health and health care and 
measures an individual’s dependence (i.e., passivity) related to health care and 
disease management. We sought to build on prior validation of the instrument 
by evaluating the reproducibility of the PDHCO and testing equivalence between 
paper and electronic administration modes. METHODS: The PDHCO and other 
questionnaires were administered to a sample of adults recruited through web-
based advertisements in 8 U.S. cities. Participants completed the PDHCO on 
paper and computerized formats in a randomized crossover design. A one-week 
retest was completed at home. Reproducibility and mode equivalence were 
assessed using the intraclass correlation coefficient (ICC). Cronbach’s alpha was 
calculated to assess internal consistency. To assess convergent validity, the 
correlation of the PDHCO to the Communication With Physician (CWP) Scale of 
the Chronic Disease Self-Efficacy Scale was calculated. ANOVA was used to 
compare mean PDHCO scores among tertiles of the Health Assertiveness Scale 
(HAS). RESULTS: Of the 230 participants that completed baseline assessment, 228 
(99.1%) completed the one-week retest. The mean age of participants was 44.3 
years, 51.3% were female, and 58.3% were Caucasian. A small number (n=9; 3.9%) 
reported their health as Poor. The mean PDHCO score was 49.7(±14.7), and the 
ICC between paper and computerized administration was 0.887. The ICC for the 
one-week retest of the paper format was 0.913, and the PDHCO was found to be 
internally consistent (Cronbach’s alpha=0.735). Significant correlations were 
found with the CWP (r=-0.246; p<.001), and the instrument discriminated 
between levels of the HAS (p<0.05). CONCLUSIONS: The PDHCO was observed to 
have adequate reproducibility and internal consistency as well as appropriate 
convergent validity. The scale was found to significantly discriminate between 
levels of health assertiveness. Equivalence between paper and web-based 
administration was demonstrated.  
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OBJECTIVES: In the absence of any pulmonary arterial hypertension (PAH)-
specific PRO instruments developed in accordance with 2009 FDA guidance 
requirements, this qualitative research study was conducted to develop a new 
instrument assessing PAH symptoms and their impacts following the PRO 
guidance. METHODS: Patient inclusion criteria were age 18–80 years and 
symptomatic PAH (WHO Group 1) diagnosed by right-heart catheterization. 
Concept elicitation was based on 5 focus groups, after which saturation of 
emergent concepts was reached. A PRO instrument for PAH symptoms and their 
impacts was drafted, considering input from the international Steering 
Committee as well as translatability and legibility assessments. Two rounds of 
cognitive interviews on the draft PRO were conducted, with instrument revisions 
following each. The study was approved by institutional review boards at 5 US 
sites and participants provided written informed consent. RESULTS: Focus 
groups comprised 25 patients, and 20 additional patients participated in 
cognitive interviews (10 per round). Participants had a mean±SD age of 54±16 
years, were predominantly female (91%), and were diverse in race/ethnicity, 
WHO functional class (FC I/II: 51%, III/IV: 49%), and etiology (associated PAH: 51%, 
idiopathic PAH: 47%, familial PAH: 2%). The draft PRO instrument was found to 
be clear, comprehensive, and relevant to PAH patients in cognitive interviews. 
Items were organized in a draft conceptual framework with 4 symptom domains 
(respiratory symptoms, tiredness, cardiovascular symptoms, other symptoms) 
and 5 impact domains (physical activities, daily activities, social impact, 
cognition, emotional impact). The recall period is the past 24 hours for symptom 
items, and 7 days for impact items. CONCLUSIONS: The draft instrument was 
shown to capture symptoms and their impacts relevant to PAH patients, 
demonstrating content saturation and concept validity. Additional testing is 
needed to confirm the content and psychometric validity of the PAH-SYMPACT 
before use in future clinical practice or studies.  
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OBJECTIVES: The valuation of health is becoming increasingly important for the 
purposes of health technology assessment. However, recent research has 
suggested that traditional preference-based measures for valuing health states 
may be flawed and life satisfaction measures may better represent the patient 
perspective. The current study extended this research by examining the validity 
of a life satisfaction measure among patients with multiple sclerosis (MS). 
METHODS: Data from the Multiple Sclerosis Patient study (N=1000) were used, 
which were collected from an Internet-based survey of patients who self-
reported a diagnosis of MS. Information on demographics, disease and treatment 
history, and health outcomes were collected. A life satisfaction measure was 
included (1=not satisfied to 7=completely satisfied) and examined alongside MS-
specific symptom and quality of life measures. RESULTS: Respondents were 
mostly female (82.8%) with an average age of 48.7 years. Most respondents had 
relapsing remitting MS (89.0%). The mean life satisfaction scores were 4.87 
(SD=1.26; IQR:4-6). Only small effects were observed between life satisfaction and 
